STAT Plus: FDA to consider new evidence, risks behind fecal matter transplants for C. diff treatment
STEVEN SENNE/AP
On Monday, the Food and Drug Administration will host its first formal discussion about fecal microbiome transplants in years.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario